Literature DB >> 16891495

Prevalence of antibodies against herpes simplex virus types 1 and 2 in children and young people in an urban region in Tanzania.

Mabula Joseph Kasubi1, Arvid Nilsen, Howard S Marsden, Tomas Bergström, Nina Langeland, Lars Haarr.   

Abstract

Herpes simplex virus type 1 (HSV-1) is transmitted by close contact, both sexual and nonsexual, and infections are acquired during childhood and adolescence. Herpes simplex virus type 2 (HSV-2), however, is thought to be transmitted mainly by sexual contact. Most HSV-2 infections are consequently expected to occur after the onset of sexual activity. Recent reports indicate an increasing prevalence of HSV-2 on the African continent, but most studies have been performed on adult cohorts. In the present study, we collected sera from Tanzanian children and young persons from 1 to 20 years old, with at least 100 individuals in each age group. Antibodies against HSV-1 and HSV-2 were detected by an in-house Western blot method which was shown to perform well in comparison with a commercial Western blot assay. Type-specific antibodies were also analyzed by two noncommercial enzyme-linked immunosorbent assay methods based upon the antigenicities of branched synthetic oligopeptides corresponding to epitopes in glycoprotein G of HSV-1 or HSV-2. The prevalence of HSV-1 antibodies increased gradually from 73% for the age group of 1 to 4 years to 92% for the age group of 17 to 20 years. The prevalence of HSV-2 antibodies was unexpectedly high, as 15% of the children were infected by the age of 8 years, with the incidence increasing gradually to 40% in the age group of 17 to 20 years. The reason for this unexpectedly high frequency is not clear but could suggest that nonsexual transmission of HSV-2 is more common than previously thought. There was no statistically significant association between seropositivities for HSV-2 and human immunodeficiency virus.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16891495      PMCID: PMC1594616          DOI: 10.1128/JCM.00180-06

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  44 in total

1.  Identification of a new glycoprotein of herpes simplex virus type 1 and genetic mapping of the gene that codes for it.

Authors:  D D Richman; A Buckmaster; S Bell; C Hodgman; A C Minson
Journal:  J Virol       Date:  1986-02       Impact factor: 5.103

2.  Genetic studies with herpes simplex virus type 1. The isolation of temperature-sensitive mutants, their arrangement into complementation groups and recombination analysis leading to a linkage map.

Authors:  S M Brown; D A Ritchie; J H Subak-Sharpe
Journal:  J Gen Virol       Date:  1973-03       Impact factor: 3.891

3.  Temperature-sensitive mutants of herpes simplex virus type 2.

Authors:  M C Timbury
Journal:  J Gen Virol       Date:  1971-11       Impact factor: 3.891

4.  Characterization of the 92,000-dalton glycoprotein induced by herpes simplex virus type 2.

Authors:  H S Marsden; A Buckmaster; J W Palfreyman; R G Hope; A C Minson
Journal:  J Virol       Date:  1984-05       Impact factor: 5.103

5.  Frequency of acquisition of first-episode genital infection with herpes simplex virus from symptomatic and asymptomatic source contacts.

Authors:  G J Mertz; O Schmidt; J L Jourden; M E Guinan; M L Remington; A Fahnlander; C Winter; K K Holmes; L Corey
Journal:  Sex Transm Dis       Date:  1985 Jan-Mar       Impact factor: 2.830

6.  The burden of infection with herpes simplex virus type 1 and type 2: seroprevalence study in Estonia.

Authors:  Anneli Uusküla; Mari Nygard-Kibur; Frances M Cowan; Philippe Mayaud; Rebecca S French; Jamie N R Robinson; David W G Brown
Journal:  Scand J Infect Dis       Date:  2004

Review 7.  Sexually transmitted herpes simplex viruses.

Authors:  Maria Karolina Jonsson; Britta Wahren
Journal:  Scand J Infect Dis       Date:  2004

8.  Comparison of Western blot (immunoblot) and glycoprotein G-specific immunodot enzyme assay for detecting antibodies to herpes simplex virus types 1 and 2 in human sera.

Authors:  R L Ashley; J Militoni; F Lee; A Nahmias; L Corey
Journal:  J Clin Microbiol       Date:  1988-04       Impact factor: 5.948

9.  Transmission of genital herpes in couples with one symptomatic and one asymptomatic partner: a prospective study.

Authors:  G J Mertz; R W Coombs; R Ashley; J Jourden; M Remington; C Winter; A Fahnlander; M Guinan; H Ducey; L Corey
Journal:  J Infect Dis       Date:  1988-06       Impact factor: 5.226

10.  Genetic relatedness of type 1 and type 2 herpes simplex viruses.

Authors:  E Kieff; B Hoyer; S Bachenheimer; B Roizman
Journal:  J Virol       Date:  1972-05       Impact factor: 5.103

View more
  17 in total

1.  Improved performance of enzyme-linked immunosorbent assays and the effect of human immunodeficiency virus coinfection on the serologic detection of herpes simplex virus type 2 in Rakai, Uganda.

Authors:  Jordyn L Gamiel; Aaron A R Tobian; Oliver B Laeyendecker; Steven J Reynolds; Rhoda Ashley Morrow; David Serwadda; Ronald H Gray; Thomas C Quinn
Journal:  Clin Vaccine Immunol       Date:  2008-03-05

2.  Subclinical Herpes Simplex Virus Type 1 Infections Provide Site-Specific Resistance to an Unrelated Pathogen.

Authors:  Alexander M Rowe; Hongming Yun; Benjamin R Treat; Paul R Kinchington; Robert L Hendricks
Journal:  J Immunol       Date:  2017-01-06       Impact factor: 5.422

Review 3.  Pathogenesis of herpes simplex keratitis: The host cell response and ocular surface sequelae to infection and inflammation.

Authors:  Ann-Marie Lobo; Alex M Agelidis; Deepak Shukla
Journal:  Ocul Surf       Date:  2018-10-11       Impact factor: 5.033

4.  Herpes simplex virus type 2 cross-sectional seroprevalence and the estimated rate of neonatal infections among a cohort of rural Malawian female adolescents.

Authors:  Christopher R Sudfeld; Paul C Hewett; Nadia N Abuelezam; Satvika Chalasani; Erica Soler-Hampejsek; Christine A Kelly; Barbara S Mensch
Journal:  Sex Transm Infect       Date:  2013-06-21       Impact factor: 3.519

5.  Safety, efficacy and delivery of multiple nucleoside analogs via drug encapsulated carbon (DECON) based sustained drug release platform.

Authors:  Tejabhiram Yadavalli; Joshua Ames; David Wu; Benjamin Ramirez; Navya Bellamkonda; Deepak Shukla
Journal:  Eur J Pharm Biopharm       Date:  2022-03-21       Impact factor: 5.589

6.  Evaluation of multiplex real-time PCR for detection of Haemophilus ducreyi, Treponema pallidum, herpes simplex virus type 1 and 2 in the diagnosis of genital ulcer disease in the Rakai District, Uganda.

Authors:  T R Suntoke; A Hardick; A A R Tobian; B Mpoza; O Laeyendecker; D Serwadda; P Opendi; C A Gaydos; R H Gray; M J Wawer; T C Quinn; S J Reynolds
Journal:  Sex Transm Infect       Date:  2008-12-09       Impact factor: 3.519

7.  Evaluation of an Automated Chemiluminescent Immunoassay in Typing Detection of IgG Antibodies Against Herpes Simplex Virus.

Authors:  Zhiyan Li; Rong Yan; Cunling Yan; Ping Liu; Zhenru Feng
Journal:  J Clin Lab Anal       Date:  2015-12-14       Impact factor: 2.352

8.  Seroepidemiology of herpes simplex virus type 1 and 2 in northern iran.

Authors:  S Rezaei-Chaparpordi; M Assmar; N Amirmozafari; L Modiri; A Massiha; S Shokri-Fashtali; Z Gholizadeh; S Akbari
Journal:  Iran J Public Health       Date:  2012-08-31       Impact factor: 1.429

9.  Diet-induced obesity prolongs neuroinflammation and recruits CCR2(+) monocytes to the brain following herpes simplex virus (HSV)-1 latency in mice.

Authors:  Katherine A White; Scott R Hutton; Jill M Weimer; Patricia A Sheridan
Journal:  Brain Behav Immun       Date:  2016-06-13       Impact factor: 19.227

10.  HIV-1, HSV-2 and syphilis among pregnant women in a rural area of Tanzania: prevalence and risk factors.

Authors:  Khadija I Yahya-Malima; Bjørg Evjen-Olsen; Mecky I Matee; Knut Fylkesnes; Lars Haarr
Journal:  BMC Infect Dis       Date:  2008-06-02       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.